From access to engagement: Measuring retention in outpatient HIV clinical care

AIDS Patient Care and STDs

Volumn 24, Issue 10, 2010, Pages 607-613

  Mugavero, Michael J ^a   Davila, Jessica A ^b   Nevin, Christa R ^a   Giordano, Thomas P ^b  

^a University of Alabama at Birmingham   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OUTPATIENT CARE; PATIENT PARTICIPATION; PERFORMANCE MEASUREMENT SYSTEM; PRIMARY MEDICAL CARE;

AMBULATORY CARE; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE;

EID: 77957998561     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2010.0086     Document Type: Article

References (30)

1. Institute of Medicine of the National Academies. Unequal Treatment: Confronting Racial and Ethnic Disparities in Healthcare. Washington, D.C.: National Academies Press; 2003.
2. Lurie N, Dubowitz T. Health disparities and access to health. JAMA 2007;297:1118-1121. (Pubitemid 46425518)
3. Bozzette SA, Berry SH, Duan N, et al. The care ofHIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med 1998;339:1897-1904.
4. Fleming P, Byers R, Sweeney P, Daniels D, Karon J, Jansen R. HIV Prevalence in the United States, 2000 [Abstract 11]. In: Program and Abstracts of the 9th Conference on Retroviruses and Opportunistic Infections. Seattle, WA: February 24-28, 2002.
5. Berg MB, Safren SA, Mimiaga MJ, Grasso C, Boswell S, Mayer KH. Nonadherence to medical appointments is associated with increased plasma HIV RNA and decreased CD4 cell counts in a community-based HIV primary care clinic. AIDS Care 2005;17:902-907.
6. Giordano TP, Gifford AL, Clinton White A, et al. Retention in care: A challenge to survival with HIV infection. Clin Infect Dis 2007;44:1493-1499.
7. Giordano TP, White AC, Jr., Sajja P, et al. Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr 2003;32:399-405.
8. Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions. Ann Intern Med 1999;131:81-87.
9. Mugavero MJ, Lin HY, Allison JJ, et al. Racial disparities in HIV virologic failure: Do missed visits matter? J Acquir Immune Defic Syndr 2009;50:100-108.
10. Mugavero MJ, Lin HY, Willig JH, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis 2009;48:248-256.
11. Park WB, Choe PG, Kim SH, et al. One-year adherence to clinic visits after highly active antiretroviral therapy: A predictor of clinical progress in HIV patients. J Intern Med 2007;261:268-275.
12. Ulett KB, Willig JH, Lin HY, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDs 2009;23:41-49.
13. Arici C, Ripamonti D, Maggiolo F, et al. Factors associated with the failure of HIV-positive persons to return for scheduled medical visits. HIV Clin Trials 2002;3:52-57.
14. Cabral HJ, Tobias C, Rajabiun S, et al. Outreach program contacts: Do they increase the likelihood of engagement and retention in HIV primary care for hard-to-reach patients? AIDS Patient Care STDs 2007;21(Suppl 1):S59-67.
15. Giordano TP, Visnegarwala F, White AC, Jr., et al. Patients referred to an urban HIV clinic frequently fail to establish care: Factors predicting failure. AIDS Care 2005;17:773-783.
16. Keruly JC, Conviser R, Moore RD. Association of medical insurance and other factors with receipt of antiretroviral therapy. Am J Public Health 2002;92:852-857.
17. Mugavero MJ. Improving engagement in HIV care: What can we do? Top HIV Med 2008;16:156-161.
18. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: Implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005;39:446-453.
19. Metsch LR, Pereyra M, Messinger S, et al. HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. Clin Infect Dis 2008;47:577-584.
20. Cohen MS, Gay C, Kashuba AD, Blower S, Paxton L. Narrative review: Antiretroviral therapy to prevent the sexual transmission of HIV-1. Ann Intern Med 2007;146:591-601.
21. Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA 2009;301:2380-2382.
22. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342:921-929.
23. Aberg JA, Kaplan JE, Libman H, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2009;49:651-681.
24. Horstmann E, Brown J, Islam F, Buck J, Agins BD. Retaining HIV-infected patients in care: Where are we? Where do we go from here? Clin Infect Dis 2010;50:752-761.
25. Melnikow J, Kiefe C. Patient compliance and medical research: Issues in methodology. J Gen Intern Med 1994;9:96-105.
26. Olatosi BA, Probst JC, Stoskopf CH, Martin AB, Duffus WA. Patterns of engagement in care by HIV-infected adults: South Carolina, 2004-2006. AIDS 2009;23:725-730.
27. Evaluating the contribution of ancillary services in improving access to primary care in the United States under the Ryan White CARE Act. AIDS Care 2002;14(Suppl 1):3-136.
28. Project Inform. TLC+: Testing, Linkage to Care and Treatment. www.projectinform.org/tlc+/ (Last accessed May 13, 2010).
29. Saag MS. Ryan White: An unintentional home builder. AIDS Reader 2009;19:166-168.
30. Chesney MA. The elusive gold standard. Future perspectives for HIV adherence assessment and intervention. J Acquir Immune Defic Syndr 2006;43(Suppl 1):S149-155.